Atlas Trials

High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes

Clinical trial NCT03403556 · UNKNOWN

Trial details

NCT number
NCT03403556
Sponsor
Yuhan Corporation
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular DiseaseType 2 Diabetes
Start date
2018-03-27
Primary completion
2021-10-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.